Work

MA04.08 Perioperative Tislelizumab for Resectable Non-small Cell Lung Cancer: Final Analysis of RATIONALE-315

Year: 2025

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.128

Authors: D. Yue, W. Wang, H. Liu, Q. Chen, C. Chen, L. Liu, G. Zhao, P. Zhang, F. Yang, G. Han, Y. Cheng, B. Yu, Y. Yang, H. Chen, J. Jiang, B. Yao, S. Wang, S. Leaw, K. Naicker, W. Zheng, C. Yu, C. Wang

Institutions: Tianjin Medical University Cancer Institute and Hospital, Hunan Cancer Hospital, Liaoning Cancer Hospital & Institute, Zhejiang Cancer Hospital, Union Hospital, Sichuan University, West China Hospital of Sichuan University, Ningbo No. 2 Hospital, Tongji University, Shanghai Pulmonary Hospital, Peking University People's Hospital, Hubei Cancer Hospital, Jilin Province Tumor Hospital, First Affiliated Hospital of Nanchang University, Peking University Cancer Hospital, Fudan University Shanghai Cancer Center, First Affiliated Hospital of Xiamen University

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519333

Cites:

Cited by: 5

Related to: 10